Publicaciones GIAS Search for: Todos201520162017201820192020202120222023 Xantinas: cafeína y otras metilxantinas. Khat Nuevas sustancias psicoactivas Alucinógenos y disociativos Trastornos relacionados con el consumo de cannabis Complicaciones médicas del consumo excesivo de alcohol Sex differences in the comorbidity of patients seeking a first treatment for Alcohol Use Disorder Usefulness of Oral Fluid for Measurement of Methylone and Its Metabolites: Correlation with Plasma Drug Concentrations and the Effect of Oral Fluid pH Sweat Testing for the Detection of Methylone after Controlled Administrations in Humans Pharmacological effects of methylone and MDMA in humans Associations of hypomagnesemia in patients seeking a first treatment of alcohol use disorder Abuse Potential of Cathinones in Humans: A Systematic Review Synthetic cannabinoids use in a sample of opioid-use disorder patients New Synthetic Opioids Use among Patients in Treatment for an Opioid Use Disorder in Barcelona New Psychoactive Substances Consumption in Opioid-Use Disorder Patients Methylone and MDMA Pharmacokinetics Following Controlled Administration in Humans BDNF and Cortisol in the Diagnosis of Cocaine-Induced Depression Vascular Endothelial Growth Factor as a Potential Biomarker of Neuroinflammation and Frontal Cognitive Impairment in Patients with Alcohol Use Disorder Prevalence and associations of metabolic syndrome in patients with alcohol use disorder Plasma Amino Acid Concentrations in Patients with Alcohol and/or Cocaine Use Disorders and Their Association with Psychiatric Comorbidity and Sex Addiction of Hallucinogens, Dissociatives, Designer Drugs and “Legal Highs”: Update on Potential Therapeutic Use Opioid Addiction and Treatment Acute Pharmacological Effects and Oral Fluid Concentrations of the Synthetic Cannabinoids JWH-122 and JWH-210 in Humans After Self-Administration: An Observational Study Interaction of energy drinks with prescription medication and drugs of Abuse Increased Natural Killer Cells Are Associated with Alcohol Liver Fibrosis and with T Cell and Cytotoxic Subpopulations Change Alcoholic liver disease among patients with Wernicke encephalopathy: a multicenter observational study Zinc deficiency and advanced liver fibrosis among HIV and hepatitis C co-infected anti-retroviral naïve persons with alcohol use in Russia Ultra-High Performance Liquid Chromatography-High Resolution Mass Spectrometry and High-Sensitivity Gas Chromatography-Mass Spectrometry Screening of Classic Drugs and New Psychoactive Substances and Metabolites in Urine of Consumers UHPLC-MS/MS analysis of cannabidiol metabolites in serum and urine samples. Application to an individual treated with medical cannabis Therapeutic potential of ayahuasca in grief: a prospective, observational study The Tryptophan System in Cocaine-Induced Depression The Shipibo Ceremonial Use of Ayahuasca to Promote Well-Being: An Observational Study The relevance of personality traits in impulsivity-related disorders: From substance use disorders and gambling disorder to bulimia nervosa The hidden web and the fentanyl problem: Detection of ocfentanil as an adulterant in heroin Plasma concentrations of granulocyte colony-stimulating factor (G-CSF) in patients with substance use disorders and comorbid major depressive disorder Patterns of use and toxicity of new para-halogenated substituted cathinones: 4-CMC (clephedrone), 4-CEC (4-chloroethcatinone) and 4-BMC (brephedrone) Oral Administration of Cannabis and Δ-9-tetrahydrocannabinol (THC) Preparations: A Systematic Review Optimal Use of Transient Elastography and Acoustic Radiation Force Impulse to Stage Liver Fibrosis in HIV/HCV-Coinfected Patients in Clinical Practice Monitoring hepatitis C virus treatment rates in an Opioid Treatment Program: A longitudinal study MDMA-induced dissociative state not mediated by the 5-HT2A receptor Markers of Monocyte Activation, Inflammation, and Microbial Translocation Are Associated with Liver Fibrosis in Alcohol Use Disorder Long-Term Outcomes of Patients With Cocaine Use Disorder: A 18-years Addiction Cohort Study HIV And HCV infection among opiate-dependent patients and methadone doses: the PROTEUS study Effects Of Mixing Energy Drinks With Alcohol On Driving-Related Skills Effect of incident hepatitis C infection on CD4+ cell count and HIV RNA trajectories based on a multinational HIV seroconversion cohort Disposition of Phytocannabinoids, Their Acidic Precursors and Their Metabolites in Biological Matrices of Healthy Individuals Treated with Vaporized Medical Cannabis Disposition of cannabinoids and their metabolites in serum, oral fluid, sweat patch and urine from healthy individuals treated with pharmaceutical preparations of medical cannabis Determination of the Synthetic Cannabinoids JWH-122, JWH-210, UR-144 in Oral Fluid of Consumers by GC-MS and Quantification of Parent Compounds and Metabolites by UHPLC-MS/MS Daidzein modulates cocaine-reinforcing effects and cue-induced cocaine reinstatement in CD-1 male mice Correlates of the use of electronic devices to vape cannabis in a cohort of young Swiss male reporting current cannabis use Comprehensive interventions for reducing cannabis use Attenuated frontal and sensory inputs to the basal ganglia in cannabis users Association of Opioid Agonist Treatment With All-Cause Mortality and Specific Causes of Death Among People With Opioid Dependence: A Systematic Review and Meta-analysis Association of hyperuricemia and gamma glutamyl transferase as a marker of metabolic risk in alcohol use disorder Assessment of liver disease in patients with chronic hepatitis C and unhealthy alcohol use Alcohol Consumption and Hepatitis C Virus (HCV) RNA Levels in HIV/HCV Coinfected Patients Acute Pharmacological Effects of Oral and Intranasal Mephedrone: An Observational Study in Humans Acute Pharmacological Effects and Oral Fluid Biomarkers of the Synthetic Cannabinoid UR-144 and THC in Recreational Users Absence of drug-drug interactions between γ-hydroxybutyric acid (GHB) and cobicistat A Comparison of Acute Pharmacological Effects of Methylone and MDMA Administration in Humans and Oral Fluid Concentrations as Biomarkers of Exposure A Biomarker to Differentiate between Primary and Cocaine-Induced Major Depression in Cocaine Use Disorder: The Role of Platelet IRAS/Nischarin (I 1-Imidazoline Receptor) Cannabis use is associated with monocyte activation (sCD163) in patients admitted for alcohol use disorder treatment Fast and sensitive UHPLC-MS/MS analysis of cannabinoids and their acid precursors in pharmaceutical preparations of medical cannabis and their metabolites in conventional and non-conventional biological matrices of treated individual LC-MS/MS method for the quantification of new psychoactive substances and evaluation of their urinary detection in humans for doping control analysis Therapeutic Use of LSD in Psychiatry: A Systematic Review of Randomized-Controlled Clinical Trials Mephedrone and Alcohol Interactions in Humans Quality of Life, Mental Health, Personality and Patterns of Use in Self-Medicated Cannabis Users with Chronic Diseases: A 12-Month Longitudinal Study Effects of cannabis exposure in the prenatal and adolescent periods: Preclinical and clinical studies in both sexes Variation in chemokines plasma concentrations in primary care depressed patients associated with Internet-based cognitive-behavioral therapy Plasma tryptophan and kynurenine pathway metabolites in abstinent patients with alcohol use disorder and high prevalence of psychiatric comorbidity Use of oipiods for chronic non-cancer pain. Reply Cocaine Use: A Threat for the HIV-Infected Liver Loss of naive T lymphocytes is associated with advanced liver fibrosis in alcohol use disorder Sex-specific associations of alcohol withdrawal in patients admitted for the treatment of alcohol use disorder MDMA interactions with pharmaceuticals and drugs of abuse Cocaine and depressive disorders: When standard clinical diagnosis is insufficient Acute Effects of 2C-E in Humans: An Observational Study Safety of nalmefene for the treatment of alcohol use disorder: an update Significance of Markers of Monocyte Activation (CD163 and sCD14) and Inflammation (IL-6) in Patients Admitted for Alcohol Use Disorder Treatment Community Screening, Identification, and Referral to Primary Care, for Hepatitis C, B, and HIV Among Homeless Persons in Los Angeles Short- And Medium-Term Impact of Bariatric Surgery on the Activities of CYP2D6, CYP3A4, CYP2C9, and CYP1A2 in Morbid Obesity Liver fibrosis and accelerated immune dysfunction (immunosenescence) among HIV-infected Russians with heavy alcohol consumption – an observational cross-sectional study Five-Year Incidence of Hospital-Based Emergencies Related to Acute Recreational Intoxication in Minors Liver Ultrasound Abnormalities in Alcohol Use Disorder Fentanyl and Related Opioids New Trends, Dangers, and Management Clinical Effects of 2C-B Abuse Meconium Biomarkers of Prenatal Alcohol Exposure Dose-Response Pharmacological Study of Mephedrone and Its Metabolites: Pharmacokinetics, Serotoninergic Effects, and Impact of CYP2D6 Genetic Variation Inflammatory mediators and dual depression: Potential biomarkers in plasma of primary and substance-induced major depression in cocaine and alcohol use disorders Soy Isoflavone Extract Does Not Increase the Intoxicating Effects of Acute Alcohol Ingestion in Human Volunteers Psychopathological symptoms associated with synthetic cannabinoid use: a comparison with natural cannabis Is moderate alcohol consumption healthy? The evolution of evidence MDMA-induced indifference to negative sounds is mediated by the 5-HT2A receptor The efficacy of computerized interventions to reduce cannabis use: A systematic review and meta-analysis Drug Interactions With New Synthetic Opioids Peripheral endocannabinoid concentrations are not associated with verbal memory impairment during MDMA intoxication Metabolic syndrome among individuals with heroin use disorders on methadone therapy: Prevalence, characteristics, and related factors Depressive mood ratings are reduced by MDMA in female polydrug ecstasy users homozygous for the l-allele of the serotonin transporter Current opioid access, use and problems in Central and Western European jurisdictions Alcohol Use in Patients with Chronic Liver Disease Cardiovascular disease burden among human immunodeficiency virus-infected individuals Metabolomics predicts the pharmacological profile of new psychoactive substances Cannabinoids: from pot to lab DSM-5 en pacientes que solicitan el primer tratamiento del trastorno por uso de alcohol. Diferencias de sexo en el estudio multicéntrico CohRTA Assessment of Efficacy and Tolerability of Medicinal Cannabinoids in Patients With Multiple Sclerosis: A Systematic Review and Meta-analysis Ultrasound findings of liver damage in a series of patients consecutively admitted for treatment of alcohol use disorder. Hepatitis C infection substantially reduces survival of alcohol-dependent patients Características de los pacientes adictos a la heroína admitidos en un programa de tratamiento con metadona Temporal trends in the survival of drug and alcohol abusers according to the primary drug of admission to treatment in Spain Emerging drugs in Europe Sex-specific disease outcomes of HIV-positive and HIV-negative drug users admitted to an opioid substitution therapy program in Spain: a cohort study Mass spectrometric evaluation of mephedrone in vivo human metabolism: identification of phase I and phase II metabolites, including a novel succinyl conjugate Impact of hepatitis C virus infection on the risk of death of alcohol-dependent patients Moderate consumption of wine, through both its phenolic compounds and alcohol content, promotes hydroxytyrosol endogenous generation in humans. A randomized controlled trial Markers of inflammation and mortality in a cohort of patients with alcohol dependence Ethanol induces hydroxytyrosol formation in humans Hepatitis C associated to substance abuse: ever closer to a treatment without Interferon Human pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) after repeated doses taken 4 h apart Human pharmacology of MDMA after repeated doses taken 4 h apart Neurocognitive performance following acute mephedrone administration, with and without alcohol Alcohol Consumption during Pregnancy: Analysis of Two Direct Metabolites of Ethanol in Meconium Human Pharmacology of Mephedrone in Comparison with MDMA Wide array of T-cell subpopulation alterations in patients with alcohol use disorders Alcohol use disorder and its impact on chronic hepatitis C virus and human immunodeficiency virus infections Non-Linear Formation of EtG and FAEEs after Controlled Administration of Low to Moderate Doses of Ethanol Monitoring nicotine intake from e-cigarettes: measurement of parent drug and metabolites in oral fluid and plasma Differences Between Alcoholic and Nonalcoholic Patients With Wernicke Encephalopathy: A Multicenter Observational Study GC-MS Quantification Method for Mephedrone in Plasma and Urine: Application to Human Pharmacokinetics Cannabis as Secondary Drug Is Not Associated With a Greater Risk of Death in Patients With Opiate, Cocaine, or Alcohol Dependence Clinical Pharmacology of the Synthetic Cathinone Mephedrone Patients with alcohol use disorder: initial results from a prospective multicenter registry in the Spanish Network on Addiction Disorders. CohRTA Study Neuropsychiatric and General Interactions of Natural and Synthetic Cannabinoids with Drugs of Abuse and Medicines Long-Term Mortality of Patients with an Alcohol-Related Wernicke-Korsakoff Syndrome Concurrent Use of Cannabis and Alcohol: Neuropsychiatric Effect Consequences Over-expression of CD8+ T-cell activation is associated with decreased CD4+ cells in patients seeking treatment of Alcohol Use Disorder Mephedrone Concentrations in Cases of Clinical Intoxication Folate deficiency in patients seeking treatment of alcohol use disorder Pharmacokinetics of Mephedrone and Its Metabolites in Human by LC-MS/MS Acute Pharmacological Effects of 2C-B in Humans: An Observational Study Key interindividual determinants in MDMA pharmacodynamics Do serum markers of liver fibrosis vary by HCV infection in patients with alcohol use disorder? La crisis de los opioides
